GH Research (GHRS) Assets (2021 - 2026)
GH Research (GHRS) posted quarterly Assets of $288.2 million for Q4 2025, up 53.09% year-over-year from $188.3 million in Q4 2024, and down 4.57% quarter-over-quarter from $302.0 million in Q3 2025.
GH Research (GHRS) Assets (2021 - 2026) Analysis & Trends
GH Research's Assets history runs 5 years deep, the most recent figure standing at $288.2 million for Q4 2025.
- In Q4 2025, Assets rose 53.09% year-over-year to $288.2 million; the TTM figure through Dec 2025 stood at $288.2 million (up 53.09% YoY), while the FY2025 annual figure was $288.2 million, up 53.09% from the prior year.
- Assets for Q4 2025 stood at $288.2 million, down from $302.0 million in the prior quarter.
- The five-year high for Assets was $320.5 million in Q1 2025, with the low at $188.3 million in Q4 2024.
- The 5-year median for Assets is $257.2 million (2022), against an average of $256.3 million.
- The sharpest annual moves came in 2024 and 2025: Assets declined 16.8% in 2024, then surged 53.09% in 2025.
- GH Research's Assets stood at $288.1 million in 2021, then decreased by 11.71% to $254.4 million in 2022, then dropped by 11.03% to $226.3 million in 2023, then dropped by 16.8% to $188.3 million in 2024, then soared by 53.09% to $288.2 million in 2025.
- Business Quant data shows GHRS's Assets at $288.2 million in Q4 2025, $302.0 million in Q3 2025, and $313.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | GH Research | 2.02 Bn | 1.68 Bn | - | 372.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 372.35 Mn |
| Dec 31, 2025 | 288.23 Mn |
| Sep 30, 2025 | 302.02 Mn |
| Jun 30, 2025 | 313.43 Mn |
| Mar 31, 2025 | 320.45 Mn |
| Dec 31, 2024 | 188.27 Mn |
| Sep 30, 2024 | 199.61 Mn |
| Jun 30, 2024 | 206.98 Mn |
| Mar 31, 2024 | 217.58 Mn |
| Dec 31, 2023 | 226.30 Mn |
| Sep 30, 2023 | 232.57 Mn |
| Jun 30, 2023 | 240.27 Mn |
| Mar 31, 2023 | 249.26 Mn |
| Dec 31, 2022 | 254.36 Mn |
| Sep 30, 2022 | 260.12 Mn |
| Jun 30, 2022 | 266.32 Mn |
| Mar 31, 2022 | 273.54 Mn |
| Dec 31, 2021 | 288.11 Mn |
| Sep 30, 2021 | 285.63 Mn |